iX Biopharma Ltd. announced that it has allotted and issued 3.8788 million new ordinary shares on Jun, 17 2026 following the exercise of warrants at 0.06 Singapore dollars per share.

The issuance lifts the company’s total share capital from 1.0575 billion shares to 1.0614 billion shares. The new shares will rank pari passu with existing shares and are expected to begin trading on the Singapore Exchange on Jun, 19 2026.

To date, 25.221 million warrants—representing 43.85% of the warrants originally issued—have been exercised, leaving 32.289 million warrants outstanding. These warrants carry an exercise price of 0.06 Singapore dollars and will expire at 5:00 p.m. on Jul, 17 2026. The final day of warrant trading will be Jul, 10 2026, with delisting scheduled for Jul, 20 2026.

Warrant holders can refer to the company’s announcement of Jun, 16 2026 or visit the corporate website for exercise procedures.